BPC-157 (Body Protection Compound-157) is one of the most extensively studied research peptides in preclinical science. This hub indexes every piece of BPC-157 content on Compound Review — from molecular mechanisms to the human evidence to regulatory status. Research use only; we do not publish dosing.
BPC-157 is not approved for any use and is sold for in-vitro research only. Almost every vendor stocks it, so the ranking below rests on what each one can prove about the vial: a named lab, a batch-matched certificate, and a dated product-page price.
Lowest price at 10/10Premier Bio Labs has the lowest 10mg price of the 6 vendors on the full score, $17.10 with code HEALTH (list $19.00), read 8 Nov. Next is MyPurePeptide at $20.00. Worked out from the dated prices. It does not change the order below.
See it at Premier Bio LabsResearch use only. Prices are list prices read from each vendor's product page on the date shown; code prices are list × (1 − the stated discount), not cart-tested. We earn a commission on partner links; the rubric does not read partner status. How we score.
For Research Purposes Only. BPC-157 is not FDA-approved for human use. All content on this page is for educational and scientific reference only. Nothing here constitutes medical advice. Always consult a qualified healthcare professional before considering any peptide protocol.
Start with the Research Overview for a complete introduction to the science.
Read Research OverviewThere is no established BPC-157 dose and we do not publish one. The research profile lists what the studies used, with citations.
View Research ProfileThe sourcing guide explains what to look for in a research-grade supplier.
Sourcing GuideThird-party HPLC-tested, ≥99% purity, COA available on every batch. Use code HEALTH for 20% off.
Comprehensive summary of 8 key studies, 6 mechanisms, evidence quality by application
How BPC-157 works at the molecular level: FAK-paxillin, NO system, angiogenesis
The 3 published human studies (2021–2025) and what they actually show
Critical analysis: what animal data can and cannot tell us about human use
Current regulatory status, the 2022 FDA warning letter, and what it means
Mechanism, the published studies with citations, and which certificate tests matter
The three small human reports and the cancelled Phase I trial, with their limits
Where the photos and timelines online come from, and what the evidence shows
How long a lyophilized vial keeps, and why an opened solution does not
What each diluent is, and why it matters for a multi-use lab vial
Head-to-head: mechanisms, applications, and why researchers often stack them
Research on concurrent use: what is and is not known about potential interactions
Why the two are discussed together, and how thin the evidence for combining them is
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in human gastric juice. It consists of 15 amino acids and has been studied in animal models for its effects on tissue repair, gut health, tendon healing, and neuroprotection. It is not FDA-approved for human use.
BPC-157 exists in a regulatory gray area in the United States. It is not FDA-approved as a drug and cannot be legally marketed for human consumption. It is sold as a research chemical for laboratory use only. The FDA issued a warning letter in 2022 regarding compounded BPC-157 preparations. See our full legal guide for details.
No. No controlled human trial has established a dose, and the amounts in animal studies were chosen for those rodent models and routes; they do not translate into a human figure. Compound Review does not publish dosing protocols. BPC-157 is sold for laboratory research only and is not for human or animal consumption.
No one can say for people. Animal studies measured tissue at time points chosen for each injury model, and no controlled human study has tracked a timeline. Week-by-week claims online are anecdotes; see BPC-157 before and after for where they come from.
BPC-157 appears to work through multiple pathways: upregulation of growth hormone receptors, stimulation of angiogenesis (new blood vessel formation), modulation of the nitric oxide system, activation of the FAK-paxillin pathway for cell migration, and interaction with the dopaminergic and serotonergic systems.
BPC-157 and TB-500 have different primary mechanisms. BPC-157 primarily works via receptor upregulation and angiogenesis, while TB-500 (Thymosin Beta-4) works through G-actin sequestration and cytoskeletal regulation. They are often stacked together for synergistic tissue repair effects.
Evidence quality analysis of BPC-157 across 8 applications — tendon repair, gut healing, neuroprotection, and more.
Published human studies on BPC-157: methodology, results, and evidence quality assessment.
Head-to-head comparison of BPC-157 and TB-500: mechanisms, healing applications, dosage, and which to choose.
Answers to the most common questions about BPC-157: dosage, safety, legality, sourcing, and research status.